Attached files
file | filename |
---|---|
10-K - ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED DECEMBER 31, 2009 - SANGUINE CORP | sanguine10kdec2009.htm |
EX-31 - 302 CERTIFICATION OF THOMAS C. DREES - SANGUINE CORP | ex311.htm |
EX-31 - 302 CERTIFICATION OF DAVID E. NELSON - SANGUINE CORP | ex312.htm |
EXHIBIT 32.1
Certification of Principal Executive Officer
Pursuant to 18 U.S.C. 1350
(Section 906 of the Sarbanes-Oxley Act of 2002)
I, Dr. Thomas Drees, Chief Executive Officer, and David Nelson, Principal Accounting Officer, of Sanguine Corporation (the "Registrant") do hereby certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of our knowledge, based upon a review of the Annual Report on Form 10-K for the period December 31, 2009, of the Registrant, as filed with the Securities and Exchange Commission on the date hereof (the "Report"):
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Dated: April 12. 2010
By: /s/ Dr. Thomas Drees
Dr. Thomas Drees
Chief Executive Officer
By: /s/ David Nelson
David Nelson, Chief Financial Officer
* A signed original of this written statement required by Section 906 has been provided to Sanguine Corporation and will be retained by Sanguine Corporation and furnished to the Securities Exchange Commission or its staff upon request.